These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 769116
21. Changes in platelet monoamine oxidase and plasma dopamine-beta-hydroxylase activities in lithium-treated bipolar patients. Sofuoğlu S, Doğan P, Köse K, Eşel E, Baştũrk M, Oğuz H, Gönül AS. Psychiatry Res; 1995 Nov 29; 59(1-2):165-70. PubMed ID: 8771233 [Abstract] [Full Text] [Related]
22. [The significance of changed monoamine oxidases in patients with psychiatric diseases]. Demisch L. Nervenarzt; 1982 Aug 29; 53(8):455-60. PubMed ID: 7133246 [No Abstract] [Full Text] [Related]
23. Platelet enzyme abnormalities in neuropsychiatric disease. Farmer PM. Ann Clin Lab Sci; 1980 Aug 29; 10(4):263-8. PubMed ID: 6108742 [Abstract] [Full Text] [Related]
24. Platelet monoamine oxidase in affective illness and alcoholism. Belmaker RH, Bracha HS, Ebstein RP. Schizophr Bull; 1980 Aug 29; 6(2):320-3. PubMed ID: 7375864 [Abstract] [Full Text] [Related]
25. An 18-month followup of students biologically at risk for psychiatric problems. Haier RJ, Buchsbaum MS, Murphy DL. Schizophr Bull; 1980 Aug 29; 6(2):334-7. PubMed ID: 7375866 [Abstract] [Full Text] [Related]
31. [Comparative characteristics of monoamine oxidases of the brain and thrombocytes]. Moskvitina TA. Vestn Akad Med Nauk SSSR; 1991 Jun 29; (10):33-6. PubMed ID: 1801459 [No Abstract] [Full Text] [Related]
33. Longitudinal assessment of MAO-, COMT-, and DBH- activity in patients with bipolar depression. Fähndrich E, Müller-Oerlinghausen B, Coper H. Int Pharmacopsychiatry; 1982 Jun 29; 17(1):8-17. PubMed ID: 6979526 [Abstract] [Full Text] [Related]
34. [Neuroleptics, monoamine oxidase inhibitors and dopamine beta hydroxylase inhibitors: their actions and interactions]. Vetulani J. Postepy Hig Med Dosw; 1973 Jun 29; 27(6):725-80. PubMed ID: 4589208 [No Abstract] [Full Text] [Related]
35. Urinary tryptamine excretion in chronic schizophrenics with low platelet MAO activity. Sullivan JL, Coffey CE, Basuk B, Cavenar JO, Maltbie AA, Zung WW. Biol Psychiatry; 1980 Feb 29; 15(1):113-20. PubMed ID: 7357050 [Abstract] [Full Text] [Related]
36. Elevated platelet MAO activity in schizophrenia-related depressive disorders. Schildkraut JJ, Orsulak PJ, Schatzberg AF, Cole JO, Gudeman JE, Rohde WA. Am J Psychiatry; 1978 Jan 29; 135(1):110-2. PubMed ID: 618506 [No Abstract] [Full Text] [Related]
37. Platelet monoamine oxidase and serum dopamine-beta-hydroxylase activity in chronic alcoholics. Sullivan JL, Stanfield CN, Schanberg S, Cavenar J. Arch Gen Psychiatry; 1978 Oct 29; 35(10):1209-12. PubMed ID: 697539 [Abstract] [Full Text] [Related]
38. Relationships between platelet and plasma monoamine oxidase, plasma dopamine-beta-hydroxylase, and urinary 3-methoxy-4-hydroxy phenylglycol. Belmaker R, Beckmann H, Goodwin F, Murphy D, Pollin W, Buchsbaum M, Wyatt R, Ciaranello P, Lamrecht F. Life Sci; 1975 Jan 15; 16(2):273-80. PubMed ID: 1110604 [No Abstract] [Full Text] [Related]
39. Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illness. III. Platelet monoamine oxidase activity in endogenous depression. Puzynski S, Hauptmann M, Zaluska M. Acta Psychiatr Scand; 1983 Feb 15; 67(2):101-8. PubMed ID: 6846038 [Abstract] [Full Text] [Related]